Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-20-005293
Filing Date
2020-04-30
Accepted
2020-04-30 18:50:44
Documents
1
Period of Report
2020-04-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 5467
  Complete submission text file 0001179110-20-005293.txt   6836
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Issuer) CIK: 0001583107 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 190 WOOSAMONSA RD PENNINGTON NJ 08534
Business Address
Smaldone Alsup Laurie (Reporting) CIK: 0001589602 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36033 | Film No.: 20837664